SCHEMBL20819606

SCHEMBL20819606

COc1cc(C)c(Br)c(C)c1C1(C(=O)O)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 1/20 0.35
▸ FYN P06241 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ GPR35 Q9HC97 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ PDE4D Q08499 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ NPSR1 Q6W5P4 2/20 0.32
▸ AKR1B10 O60218 1/20 0.32
▸ AKR1C4 P17516 1/20 0.32
▸ AKR1C3 P42330 1/20 0.32
▸ AKR1C2 P52895 1/20 0.32
▸ AKR1C1 Q04828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20819536 0.86 CYP3A4 (0.36) KDM4EALDH1A1HSD17B10HPGDGPR35
SCHEMBL20819549 0.81 HPGD (0.40) KDM4EALDH1A1HSD17B10HPGDGPR35
SCHEMBL20819563 0.79 HSD17B10 (0.32) KDM4EALDH1A1HSD17B10HPGDGPR35
SCHEMBL20819588 0.78 ALDH1A1 (0.45) ALDH1A1HSD17B10PDE4DMEN1KMT2A
SCHEMBL20819553 0.77 ALDH1A1 (0.41) ALDH1A1PDE4DMAPTMEN1KMT2A
SCHEMBL20790295 0.77 LMNA (0.40) KDM4EALDH1A1HPGDRXFP1PDE4D
SCHEMBL31045607 0.76 MAP3K14 (0.41) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL20819540 0.75 TSHR (0.40) LCKFYNALDH1A1HPGDMAPT
SCHEMBL20819738 0.73 RXRA (0.36) KDM4EHSD17B10GPR35MAPTMEN1
SCHEMBL20819590 0.73 ALDH1A1 (0.41) KDM4EALDH1A1MAPTKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681864-A1 MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE AbbVie Overseas S.à r.l. (LU) 2020-07-22 — — EP disclosed
WO-2019053634-A1 MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE AbbVie S.à.r.l. (LU) 2019-03-21 — — WO disclosed
Send feedback